The rising burden of infectious diseases across developed and emerging economies is encouraging healthcare organizations and governments to invest in antiviral therapeutics research and development. Additionally, expanding access to healthcare services and increasing demand for effective treatment options are contributing to market growth. Pharmaceutical manufacturers are also strengthening...